Vitamin K Deficiency

Overview

Plain-Language Overview

Vitamin K deficiency is a condition where the body lacks enough vitamin K, a nutrient essential for blood clotting. This deficiency mainly affects the blood system, leading to problems with stopping bleeding. People with this condition may experience easy bruising, bleeding gums, or prolonged bleeding from cuts. It can also cause serious internal bleeding, especially in newborns or people with certain medical problems. The deficiency can result from poor diet, certain medications, or diseases that affect vitamin absorption. Overall, it impairs the body's ability to form blood clots, which are crucial to prevent excessive bleeding.

Clinical Definition

Vitamin K deficiency is a disorder characterized by insufficient levels of vitamin K, a fat-soluble vitamin required for the gamma-carboxylation of glutamic acid residues on clotting factors II, VII, IX, and X, as well as proteins C and S. The deficiency typically arises from inadequate dietary intake, malabsorption syndromes (such as cystic fibrosis or celiac disease), or use of vitamin K antagonists like warfarin. It leads to impaired synthesis of functional clotting factors, resulting in a bleeding diathesis with prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT). Clinically, it manifests as mucocutaneous bleeding, easy bruising, and in severe cases, life-threatening hemorrhage. Newborns are particularly vulnerable due to low placental transfer and sterile intestines lacking vitamin K-producing bacteria. Prompt recognition is critical to prevent complications such as intracranial hemorrhage.

Inciting Event

Inadequate dietary intake or supplementation of vitamin K.
Disruption of intestinal microbiota by antibiotics.
Biliary obstruction or cholestasis reducing fat-soluble vitamin absorption.
Use of vitamin K antagonists such as warfarin.
Severe malabsorption due to gastrointestinal diseases.

Latency Period

Hours to days in neonates presenting with hemorrhagic disease of the newborn.
Several days to weeks after antibiotic initiation in adults due to depletion of gut flora.
Variable latency depending on severity of malabsorption or liver dysfunction.
Rapid onset within days after starting warfarin without vitamin K supplementation.

Diagnostic Delay

Nonspecific bleeding symptoms often attributed to other causes.
Lack of awareness of vitamin K deficiency in adults with malabsorption or liver disease.
Normal platelet count and fibrinogen levels may mislead clinicians away from coagulopathy.
Failure to measure prolonged prothrombin time (PT) early in bleeding evaluation.
Misinterpretation of bleeding as due to thrombocytopenia or other hematologic disorders.

Clinical Presentation

Signs & Symptoms

Easy bruising and spontaneous bleeding
Gastrointestinal bleeding presenting as melena or hematemesis
Hematuria or bleeding from urinary tract
Nosebleeds (epistaxis) and bleeding gums
Hemarthrosis is rare but may occur in severe deficiency

History of Present Illness

Spontaneous mucosal bleeding, including epistaxis and gum bleeding.
Easy bruising and petechiae without trauma.
Prolonged bleeding from minor wounds or invasive procedures.
Gastrointestinal bleeding or hematuria in severe cases.
In neonates, bleeding from the umbilical stump or intracranial hemorrhage.

Past Medical History

Recent or chronic antibiotic use affecting gut flora.
History of liver disease or cholestasis such as cirrhosis or biliary atresia.
Malabsorption syndromes including celiac disease or pancreatic insufficiency.
Use of vitamin K antagonists like warfarin without adequate monitoring.
Neonatal history lacking vitamin K prophylaxis at birth.

Family History

Usually no familial inheritance as vitamin K deficiency is acquired.
Rarely, hereditary defects in vitamin K metabolism such as mutations in vitamin K epoxide reductase complex may be reported.
Family history of bleeding disorders may prompt evaluation but is distinct from vitamin K deficiency.
No consistent association with heritable coagulopathies like hemophilia.

Physical Exam Findings

Petechiae and ecchymoses due to impaired clotting factor activation
Mucosal bleeding such as gingival bleeding or epistaxis
Prolonged bleeding from venipuncture or minor trauma
Hematomas or deep tissue bleeding in severe deficiency
Jaundice may be present if associated with liver disease

Diagnostic Workup

Diagnostic Criteria

Diagnosis of vitamin K deficiency is established by a combination of clinical bleeding symptoms and laboratory findings of a prolonged prothrombin time (PT) with or without prolonged activated partial thromboplastin time (aPTT). The key confirmatory test is the rapid correction of coagulation abnormalities after administration of vitamin K. Normal platelet count and fibrinogen levels help exclude other coagulopathies. Measurement of undercarboxylated prothrombin (PIVKA-II) can also support the diagnosis in uncertain cases.

Pathophysiology

Key Mechanisms

Impaired gamma-carboxylation of vitamin K-dependent clotting factors II, VII, IX, and X leads to decreased coagulation activity.
Reduced activation of anticoagulant proteins C and S contributes to a complex coagulation imbalance.
Deficiency of vitamin K epoxide reductase impairs recycling of vitamin K, limiting its availability for clotting factor activation.
Decreased synthesis of functional clotting factors results in prolonged prothrombin time (PT) and bleeding tendency.

Involvement	Details
Organs	Liver is the primary organ responsible for producing functional clotting factors dependent on vitamin K.
Organs	Intestines contribute to vitamin K status through absorption of dietary vitamin K and production by gut microbiota.
Tissues	Liver tissue is the site of synthesis of vitamin K-dependent clotting factors and is critical in the pathophysiology of deficiency.
Cells	Hepatocytes synthesize vitamin K-dependent clotting factors essential for normal coagulation.
Cells	Platelets contribute to hemostasis but are functionally normal in isolated vitamin K deficiency.
Chemical Mediators	Vitamin K is a crucial cofactor for gamma-glutamyl carboxylase, enabling activation of clotting factors II, VII, IX, and X.
Chemical Mediators	Prothrombin time (PT) is prolonged due to decreased activity of vitamin K-dependent clotting factors.

Treatments

Pharmacological Treatments

Vitamin K1 (Phytonadione)
- Mechanism:
  - Replenishes vitamin K stores to enable gamma-carboxylation of clotting factors II, VII, IX, and X.
- Side effects:
  - Hypersensitivity reactions
  - Flushing
  - Injection site pain
- Clinical role:
  - First-line
Fresh frozen plasma
- Mechanism:
  - Provides immediate replacement of functional vitamin K-dependent clotting factors.
- Side effects:
  - Volume overload
  - Allergic reactions
  - Transfusion-related acute lung injury
- Clinical role:
  - Adjunctive

Non-pharmacological Treatments

Identify and treat underlying causes such as malabsorption or antibiotic overuse to restore normal vitamin K levels.
Supportive care including monitoring and managing bleeding complications with local hemostatic measures.

Prevention

Pharmacological Prevention

Vitamin K supplementation orally or parenterally in at-risk populations
Prophylactic vitamin K administration to newborns to prevent hemorrhagic disease
Adjustment of warfarin dose with vitamin K monitoring to prevent deficiency
Use of vitamin K antagonists only under close supervision to avoid deficiency

Non-pharmacological Prevention

Ensuring adequate dietary intake of vitamin K–rich foods such as leafy greens
Screening for malabsorption disorders in patients with bleeding tendencies
Avoidance of broad-spectrum antibiotics that disrupt gut flora unnecessarily
Monitoring and managing liver disease to preserve vitamin K metabolism
Education on bleeding risk and early signs in patients on anticoagulants

Outcome & Complications

Complications

Severe hemorrhage including intracranial bleeding
Hypovolemic shock from uncontrolled bleeding
Anemia secondary to chronic blood loss
Death if bleeding is not promptly controlled

Short-term Sequelae	Long-term Sequelae
Acute bleeding episodes requiring urgent intervention Hemodynamic instability from blood loss Need for blood transfusions or plasma products Delayed wound healing due to impaired clot formation	Chronic anemia from recurrent bleeding Neurological deficits from intracranial hemorrhage Fibrosis or scarring at sites of repeated bleeding Increased morbidity and mortality if underlying cause is not corrected

Differential Diagnoses

Vitamin K Deficiency versus Disseminated Intravascular Coagulation (DIC)

Vitamin K Deficiency	Disseminated Intravascular Coagulation (DIC)
Prolonged PT with normal or mildly prolonged aPTT and normal fibrinogen	Prolonged PT and aPTT with decreased fibrinogen and elevated D-dimer
Gradual onset related to vitamin K deficiency or malabsorption	Acute onset with rapid progression and multiorgan failure
History of malnutrition, antibiotic use, or biliary obstruction	Recent severe infection, trauma, or malignancy

Vitamin K Deficiency versus Liver Disease (Cirrhosis or Hepatic Failure)

Vitamin K Deficiency	Liver Disease (Cirrhosis or Hepatic Failure)
Prolonged PT with normal liver enzymes and normal albumin	Prolonged PT and aPTT with elevated liver enzymes and low albumin
Subacute or chronic course without liver synthetic dysfunction	Chronic progressive course with signs of portal hypertension
Normal liver imaging or no evidence of fibrosis	Imaging showing cirrhosis or hepatic fibrosis

Vitamin K Deficiency versus Hemophilia A or B

Vitamin K Deficiency	Hemophilia A or B
Prolonged PT with normal or mildly prolonged aPTT	Isolated prolonged aPTT with normal PT
No inheritance pattern; acquired deficiency	X-linked recessive inheritance
Bleeding primarily related to impaired clotting factor carboxylation	Recurrent spontaneous hemarthroses and deep tissue bleeding

Vitamin K Deficiency versus Warfarin Toxicity

Vitamin K Deficiency	Warfarin Toxicity
No exposure to anticoagulant drugs	Recent use of vitamin K antagonist medication
Prolonged PT with normal platelet count but no anticoagulant exposure	Prolonged PT and elevated INR with normal platelet count
Improvement with vitamin K but no prior anticoagulant use	Rapid correction of coagulopathy with vitamin K administration

Vitamin K Deficiency versus Platelet Dysfunction (e.g., Uremia, Aspirin Use)

Vitamin K Deficiency	Platelet Dysfunction (e.g., Uremia, Aspirin Use)
Prolonged PT with normal or mildly prolonged aPTT and normal bleeding time	Normal PT and aPTT with prolonged bleeding time
No history of platelet-inhibiting drugs or renal failure	History of aspirin or NSAID use or chronic kidney disease
Bleeding tendency involving deep tissues and mucosa	Mucocutaneous bleeding without deep tissue hemorrhage